A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models
| dc.creator | Nivea Pereira de Sá | |
| dc.creator | Eleftherios Mylonakis | |
| dc.creator | Carlos Augusto Rosa | |
| dc.creator | Daniel Assis Santos | |
| dc.creator | Susana Johann | |
| dc.creator | Caroline M. Lima | |
| dc.creator | Juliana R. A. Santos | |
| dc.creator | Marliete Carvalho Costa | |
| dc.creator | Patricia P. Barros | |
| dc.creator | Juliana Campos Junqueira | |
| dc.creator | Jéssica Aparecida Vaz | |
| dc.creator | Renata Barbosa de Oliveira | |
| dc.creator | Beth Burgwyn Fuchs | |
| dc.date.accessioned | 2024-08-05T20:07:17Z | |
| dc.date.accessioned | 2025-09-08T23:38:33Z | |
| dc.date.available | 2024-08-05T20:07:17Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Objetivo: Neste trabalho testamos 2-(2-(ciclohexilmetileno)hidrazinil)-4-feniltiazol (CHT) contra Cryptococcus spp. e Candida albicans. Métodos: Foi avaliada a capacidade da CHT de atuar no biofilme e também de interferir na adesão de C. albicans, bem como a eficiência da CHT em modelos invertebrados e murinos de criptococose e candidíase. Resultados e conclusão: No presente trabalho verificamos que a CHT inibe Cryptococcus e C. albicans afetando o biofilme em ambos e inibe a adesão de Candida às células bucais humanas. Quando avaliamos in vivo, a CHT prolongou a sobrevivência de Galleria mellonella após infecções por Cryptococcusgattii, Cryptococcusneoformans ou C. albicans e promoveu redução na carga fúngica para os órgãos nos modelos murinos. Estes resultados demonstram o potencial terapêutico da CHT. | |
| dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | |
| dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.4155/fsoa-2018-0001 | |
| dc.identifier.issn | 2056-5623 | |
| dc.identifier.uri | https://hdl.handle.net/1843/72649 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Future Science OA | |
| dc.rights | Acesso Aberto | |
| dc.subject | Antifúngicos | |
| dc.subject | Candida albicans | |
| dc.subject | Camundongos | |
| dc.subject | Tiazóis | |
| dc.subject | Virulência | |
| dc.subject.other | Antifungal | |
| dc.subject.other | Candida albicans | |
| dc.subject.other | Cryptococcus spp. | |
| dc.subject.other | Galleria mellonella | |
| dc.subject.other | Mice | |
| dc.subject.other | Thiazole | |
| dc.subject.other | Virulence | |
| dc.title | A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models | |
| dc.type | Artigo de periódico | |
| local.citation.issue | 6 | |
| local.citation.volume | 4 | |
| local.description.resumo | Aim: In this work we test 2-(2-(cyclohexylmethylene)hydrazinyl)-4-phenylthiazole (CHT) against Cryptococcus spp. and Candida albicans. Methods: The ability of CHT to act in biofilm and also to interfere with C. albicans adhesion was evaluated, as well as the efficiency of the CHT in cryptococcosis and candidiasis invertebrate and murine models. Results & conclusion: In the present work we verified that CHT is found to inhibit Cryptococcus and C. albicans affecting biofilm in both and inhibited adhesion of Candida to human buccal cells. When we evaluated in vivo, CHT prolonged survival of Galleria mellonella after infections with Cryptococcusgattii, Cryptococcusneoformans or C. albicans and promoted a reduction in the fungal burden to the organs in the murine models. These results demonstrate CHT therapeutic potential. | |
| local.identifier.orcid | https://orcid.org/0000-0003-0901-6909 | |
| local.identifier.orcid | https://orcid.org/0000-0002-4624-0777 | |
| local.identifier.orcid | https://orcid.org/0000-0002-1108-5666 | |
| local.identifier.orcid | https://orcid.org/0000-0001-8068-1720 | |
| local.identifier.orcid | https://orcid.org/0000-0003-0381-9225 | |
| local.identifier.orcid | https://orcid.org/0000-0001-6646-6856 | |
| local.identifier.orcid | https://orcid.org/0000-0001-5233-1221 | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS | |
| local.publisher.department | ICB - DEPARTAMENTO DE BOTÂNICA | |
| local.publisher.department | ICB - DEPARTAMENTO DE MICROBIOLOGIA | |
| local.publisher.department | ICX - DEPARTAMENTO DE QUÍMICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.tandfonline.com/doi/full/10.4155/fsoa-2018-0001 |
Arquivos
Pacote original
1 - 1 de 1
Carregando...
- Nome:
- A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models.pdf
- Tamanho:
- 805.79 KB
- Formato:
- Adobe Portable Document Format
Licença do pacote
1 - 1 de 1